JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95
Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $106
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $83
Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $85
JP Morgan Maintains Overweight on Merit Medical Systems, Lowers Price Target to $77
Loading...